ESCCseeker

There is 1 paper on ESCCseeker in aging research: 1 observational study in people.

Biomarker

1 paper studies it2 findings

1 new paper in 30 daysSee all 1 papers on ESCCseeker

“ESCCseeker demonstrates robust performance (AUC: 0.987 training, 0.966 test, 0.943 verification), outperforming conventional biomarkers.”
A peripheral blood mononuclear cell DNA methylation-based risk stratification tool for esophageal squamous cell carcinomaCell reports. Medicine2026doi:10.1016/j.xcrm.2026.103132
  • Humans1

Effects

1

Number of endoscopies needed

downin humans1

1 study
  1. ESCCseeker is linked with lower number of endoscopies needed in humans (25.02 to 4.78; 83% of unnecessary procedures avoided while preserving >90% detection sensitivity).

    “Restricting endoscopy to high-risk individuals reduces the number of endoscopies needed from 25.02 to 4.78, avoiding 83% of unnecessary procedures while preserving >90% detection sensitivity.”

    Humansprospective multicenter cohort; endoscopy restricted to individuals classified as high risk

    A peripheral blood mononuclear cell DNA methylation-based risk stratification tool for esophageal squamous cell carcinoma

    Cell reports. Medicine

Associations

1

Esophageal squamous cell carcinoma discrimination

upin humans1

1 study
  1. ESCCseeker predicts esophageal squamous cell carcinoma discrimination in humans (verification cohort) (AUC: 0.987 training, 0.966 test, 0.943 verification).

    “ESCCseeker demonstrates robust performance (AUC: 0.987 training, 0.966 test, 0.943 verification), outperforming conventional biomarkers.”

    Humansverification cohortperipheral blood mononuclear cell

    A peripheral blood mononuclear cell DNA methylation-based risk stratification tool for esophageal squamous cell carcinoma

    Cell reports. Medicine

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months